Schizophrenia is a devastating neurodevelopmental disorder with a complex genetic etiology. Widespread cortical gray matter loss has been observed in patients and prodromal samples. However, it remains unresolved whether schizophrenia-associated cortical structure variations arise due to disease etiology or secondary to the illness. Here we address this question using a partitioningbased heritability analysis of genome-wide single-nucleotide polymorphism (SNP) and neuroimaging data from 1750 healthy individuals. We find that schizophrenia-associated genetic variants explain a significantly enriched proportion of trait heritability in eight brain phenotypes (false discovery rate = 10%). In particular, intracranial volume and left superior frontal gyrus thickness exhibit significant and robust associations with schizophrenia genetic risk under varying SNP selection conditions. Cross-disorder comparison suggests that the neurogenetic architecture of schizophrenia-associated brain regions is, at least in part, shared with other psychiatric disorders. Our study highlights key neuroanatomical correlates of schizophrenia genetic risk in the general population. These may provide fundamental insights into the complex pathophysiology of the illness, and a potential link to neurocognitive deficits shaping the disorder.
INTRODUCTION
Schizophrenia is a common and devastating brain disorder with a strong genetic basis (heritability h 2~8 0%). 1 Neuroimaging studies have reported widespread brain anatomical changes as potential pathogenic features of the disorder.
2 Such brain alterations have been linked to various clinical symptoms, encompassing cognitive impairment, 3 auditory hallucinations, [4] [5] [6] [7] and social dysfunction. 8 Nevertheless, a major question remains unanswered: which of the structural changes reflect a shared genetic basis with disease etiology-and thus are potential endophenotypes, 9 or arise secondary to disease progression or treatment-related mechanisms. 10 Studies of patients, although unquestionably informative, have encountered multiple challenges, including confounding effects of drugs and comorbidity conditions, and genetic, clinical heterogeneity of the patient population.
The emerging availability of large-scale cohorts of unaffected individuals with neuroimaging and genotype data provides a unique opportunity to gain insight into the shared genetic basis of brain anatomy and disease. As with many other complex disorders, schizophrenia is highly polygenic 11 and genetic vulnerability to the disorder lies on a continuum across health and disease. 12 Therefore, examining the relationship between normal variation in brain anatomy and genetic liability to schizophrenia has the potential to reveal neuroanatomical correlates of schizophrenia disease risk. Traditionally, effects of individual schizophrenia risk variants or aggregated polygenic disease burden have been studied on a prioritized list of brain imaging traits. [13] [14] [15] These works have yielded key discoveries. For example, accumulating evidence suggests that dysregulated prefrontal cortex function 14, [16] [17] [18] and white matter connectivity 19, 20 index inherited schizophrenia disease risk.
Here we use a partitioning-based heritability analysis to investigate the shared genetic basis of brain anatomy and schizophrenia risk using genome-wide single-nucleotide polymorphism (SNP) data. Linear mixed-effects models 21 provide a powerful means to quantify heritability of major psychiatric disorders [22] [23] [24] and brain structural traits. 25, 26 By utilizing the genetic similarity between unrelated individuals, this method can estimate the heritability of a phenotype without family or twin data. Furthermore, by partitioning the genome-wide variants into biologically meaningful categories, SNP heritability analysis has illustrated the genetic architecture of various human traits.
We use the genomic partitioning strategy to identify brain phenotypes for which normal variation is significantly modulated by schizophrenia-risk variants. 27, 28 Our central hypothesis is that independently ascertained schizophrenia-associated variants will explain a significantly enriched proportion of the phenotypic variation for brain traits that share a genetic basis with the disease. Here we tested this hypothesis using neuroimaging and genomewide SNP data from 1750 healthy young adults. [31] [32] [33] [34] By identifying key neuroanatomical correlates of schizophrenia genetic risk in the general population, we ultimately aim to provide key insights into the complex pathophysiology of the illness, and a potential link to neurocognitive deficits shared across diverse psychiatric disorders.
MATERIALS AND METHODS

Study subjects
Our neuroimaging genetics sample consists of 2795 healthy subjects collected in two independent studies: the Harvard/ Massachusetts General Hospital (MGH) Brain Genomics Superstruct Project (GSP; N = 1817) 32, 33 and the Queensland Twin Imaging Study (QTIM; N = 978). 31, 34 The GSP project recruited over 3000 native English-speaking healthy adults between October 2008 and March 2013 from Harvard University, MGH, and the surrounding Boston communities. Participants were assessed for their physical health, past and present history of psychiatric illness, medication usage, family history of psychiatric illness, and alcohol/tobacco/caffeine usage. Participants were excluded if they reported a history of head trauma, current/past Axis I pathology or neurological disorder, current/past psychotropic medication usage, acute physical illness and/or loss of consciousness. Data analyses in this study were restricted to 1340 young adults (18) (19) (20) (21) (22) (23) (24) (25) (26) (27) (28) (29) (30) (31) (32) (33) (34) (35) The QTIM is a neuroimaging project that studies genetic influences on brain structure and function using healthy young adult twins. Each member of twin pairs and their siblings were assessed using extensive diagnostic interviews to exclude anyone with a history of brain disorders, diseases, injuries or substance abuse. Written informed consent was obtained from all participants. We restricted analysis to self-identified Caucasian subjects with both structural magnetic resonance imaging (MRI) scans and genome-wide SNP data. We also included only unrelated individuals in the QTIM to minimize potential biases that may arise if family and unrelated population samples are used together in subsequent heritability analysis. Between each of the twin pairs, one subject was selected at random. The final study samples consisted of 515 unrelated subjects (age, 22.99 ± 3.21 years; female 63.35%). All subjects were right-handed. The QTIM study was approved by the Human Research Ethics Committees of the QIMR Berghofer Medical Research Institute, University of Queensland, and Uniting Health Care, Wesley Hospital.
Imaging data acquisition and processing For GSP, high-resolution structural brain MR images were collected on matched 3T Tim Trio scanners (Siemens, Erlangen, Germany) at Harvard University and MGH using the 12 or 32 channel phased array head coil. Structural data included a high-resolution multiecho T1-weighted magnetization-prepared gradient-echo image (multi-echo MP-RAGE; time of repetition (TR) = 2200 ms, time inversion (TI) = 1100 ms, time echo (TE) = 1.54 ms for image 1-7.01 ms for image 4, flip angle = 7º, resolution 1.2 × 1.2 × 1.2 mm and field of view = 230). An optimized study reference template was generated from 700 subjects available through the existing data set. FreeSurfer (v.4.5.0) 35 was used to process the structural brain MRI scans and to compute global and regional morphological measurements. In the QTIM cohort, structural MRI scans were obtained on a single 4-tesla scanner (Bruker Medspec, Alexandria, NSW, Australia). T1-weighted 3D structural images were acquired with an inversion recovery rapid gradient echo sequence (MPRAGE; TR = 1500 ms; TE = 3.35 ms; flip angle = 8°; slice thickness = 0.9 mm, with a 256 acquisition matrix; with a final voxel resolution = 0.9 × 0.9 × 0.9 mm). Quality control procedures for imaging data were described in detail in our previous work. 32, 34 In brief, images were screened for artefacts, acquisition problems, processing errors and excessive motion. Each image was examined on a per-slice basis along each principal axis. Typical data quality issues included electronic noise resulting in bright lines through multiple slices, motion artefacts appearing as hazy bands across the image, poor head positioning resulting in wraparound artefacts, distortions from dental work, and limited image contrast. Anatomical scans were then processed through FreeSurfer (5.3.0) in a fully automated manner, without manual corrections. The resulting data were visually inspected for errors. In both data sets, average cortical thickness and surface area measurements were extracted from 68 cortical brain regions (34 regions per hemisphere) defined by the Desikan-Killiany atlas. 36 We also included three global brain phenotypes: intracranial volume (ICV), total cortical surface area and average cortical thickness. We did not include regional volumetric measures as they are a mixture of, and largely genetically correlated with cortical thickness and surface area measurements. 37 Genotyping and data quality control SNP genotyping was conducted using Illumina OmniExpress BeadChip (San Diego, CA, USA) and Human610-Quad BeadChip for GSP and QTIM, respectively. Both data sets were processed with the same genetics protocol for standardized and stringent quality control (QC). 38 SNP markers were excluded if they have genotyping call rates o 99.8%, minor allele frequency o1%, and Hardy-Weinberg equilibrium P o 1 × 10 − 2 . Subjects were excluded by checking sex discrepancy, cryptic relatedness (π40.125) or low genotyping call rates (o 99%). PLINK multidimensional scaling analysis was used to exclude population outliers with respect to HapMap 3 European reference samples. To adjust for potential sub-population stratification, we performed principal component analysis using EIGENSOFT 39 (web resources). After these QC steps, 460 656 SNPs remained for 1308 subjects in GSP. Genotyping call rate was 0.99967. In QTIM, 500 332 SNPs remained for 442 independent subjects. Genotyping call rate was 0.999726.
Genome-wide heritability analyses of brain anatomical measures The narrow-sense heritability, h 2 g , is defined for each trait as the proportion of total phenotypic variance in the population that is explained by additive genetic factors. As previously described, 21 the linear mixed-effects modeling method estimates h 2 g by: (1) calculating the kinship matrix using the genotypic relatedness matrix (GRM) from high-density SNP data; and (2) estimating variance explained by the GRM jointly with a residual component using the restricted maximum likelihood (REML) strategy. Therefore, h ð ÞþvarðeÞ , where var(g) and var(e) are the genetic and residual variance components estimated by the REML approach. The variation of the variance component estimates is estimated from the inverse Fisher information and propagated using a first-order Taylor expansion. In the present study, we used GCTA 21 (web resources) to calculate the GRM and to estimate heritability h 2 g for examined brain traits conditioned on age, sex, handedness, scanner, console, coil types and top four principal components of ancestry in each study. All analyses of surface area and global brain volumetric measures were adjusted for ICV to account for unexplained variability due to head size. 40 Heritability estimates were set between zero and one. As previously noted, only unrelated subjects were used in the heritability analysis in both GSP and QTIM. To further prevent an effect of cryptic relatedness, subjects were excluded if corresponding elements in the GCTA GRM 40.025. Heritability estimate results from the GSP and QTIM samples were meta-analyzed using a fixed-effects inverse-variance-weighted approach. The power analysis using the GCTA-GREML Power Calculator (web resource) indicates that using our sample size of 1750 subjects, we have the power of 80.49% to estimate the SNP heritability of 0.8 at the type I error rate of 3.60 × 10 -4 (α = 0.05/139; Bonferroni corrected for examining 139 measures).
Genomic partitioning of heritability using schizophrenia GWAS loci We obtained the latest genome-wide SNP analysis results of schizophrenia 41 from the Psychiatric Genomics Consortium (PGC; web resource). The association summary statistics consisted of the meta analysis results of 9 270 274 autosomal SNPs using 36 989 cases and 113 075 controls. SNPs were filtered by imputation quality (IMPUTE INFO score R 2 o0.8) and minor allele frequencyo 0.01. In each data set, genotyped SNPs were ranked based on disease-association P-values from the PGC study, and the top 10% of the genotyped SNPs were retained as disease-associated SNPs. Two GRMs were then calculated based on the set of selected schizophrenia (SCZ)-associated SNPs and the set of remaining genotype SNPs, respectively. Joint analysis of the two genetic components was performed to estimate the genome-wide SNP heritability as a sum of h 2 SCZ-GWAS (attributed to SCZ-associated SNPs) and h 2 C(SCZ-GWAS) (attributed to a complementary, unselected genotype SNP set). As described by Yang et al. 21 joint analysis of the two GRMs as random effects prevents inflated estimates of local SNP heritability. As in the genome-wide SNP heritability analysis, age, sex, handedness, site, scanner, coil and top four principal components were included as covariates in the REML. We provide the detailed summary of the partitioning-based SNP heritability analysis in the Supplementary Method.
Enrichment analysis
We tested whether observed partial heritability h 2 SCZ-GWAS is higher than what would be expected under uniform contribution of genotyped SNPs using the Monte Carlo simulation approach detailed in Toro et al. 42 First, we calculated the SNP-set heritability expected under no enrichment as f × h 2 g , the multiplication of the fraction f of the genome corresponding to each SNP set and the genome-wide heritability estimate h 2 g . The f was calculated as the proportion of the number of SNPs n in a given set over the total number of N genotype SNPs. The Z score was constructed to test whether the observed partial heritability h 2 SCZ-GWAS is significantly larger than f × h 2 g as below:
. We calculated the empirical significance of enrichment by comparing the observed Z score to those from 100 000 random permutations, where we assigned n randomly selected genotype SNPs as the SCZ-genomewide association statistics (GWAS) SNP set and the remaining unselected SNPs as the other set, and applied partitioning-based heritability analysis. To adjust for multiple testing across brain regions, we used the false discovery rate (FDR) approach. Genomic partitioning of heritability using other psychiatric disorder GWAS loci We obtained GWAS for five psychiatric disorders 43 from the PGC (web resource). The disorders included: bipolar disorder (N = 11 810), major depressive disorder (N = 16 610), attention deficit hyperactivity disorder (ADHD; N = 5422), autism spectrum disorder (N = 10 263) and anorexia nervosa (N = 17 767). As a control data set, we also examined GWAS results from Crohn's disease obtained from the International Inflammatory Bowel Disease Genetics Consortium (N = 20 883; web resource). The heritability estimation and enrichment analysis procedure was identical to that of schizophrenia.
RESULTS
Genome-wide linear mixed-effects modeling nominates 35 brain anatomical traits with significant SNP heritability Our study sample consisted of 2795 unrelated healthy subjects of European ancestry recruited in two neuroimaging genetics studies: the Harvard/MGH Genomic SuperStruct Project (GSP; N = 1817) 32, 33 and the QTIM (N = 978). 31, 34 After unified and stringent QC of genotype and imaging data, we retained a total of 1750 unrelated young adult subjects (age 18-35 years). We first estimated the genome-wide SNP heritability h 2 g of 139 brain anatomical measures. Target regions of interest included 3 global and 136 left/right lateral measurements for cortical thickness and surface areas (34 regions per hemisphere) defined by the DesikanKilliany atlas. 36 Estimated heritability varied across brain structures (Supplementary Table 1 ). Among three global traits, significant SNP heritability was found for ICV (h (Table 1) , and thus were forwarded to subsequent partitioning analyses. Using LD-pruned SNPs did not significantly change the results (Supplementary Table 2 ). Figure 1 . Estimates of SNP heritability explained by independently ascertained schizophrenia-associated SNPs compared with the null expectation. The disease-associated SNP selection procedure is as follows: all genotyped SNPs were ranked based on the results of the recent genome-wide case/control association study of schizophrenia, obtained from the Psychiatric Genomics Consortium. On the basis of the rank, disease-associated SNPs were selected to consist of 10% of the genotyped SNPs in our data set, and the remaining 90% of SNPs were assigned as non-associated SNPs. GCTA was used to perform a joint analysis of two set-based genetic components. The y-axis represents 35 brain anatomical traits separated into three groups: (1) global anatomical measures; (2) cortical thickness; and (3) surface area measurements. The xaxis represents estimated schizophrenia-set-based SNP heritability for a respective trait. Estimated heritability is displayed by a solid navycolor bar, while the null expectation (that is, estimates calculated based on the proportion of SNPs with respect to genome-wide SNP heritability) is shown by a dashed gray-line bar. Error bars represent the s.e.'s of the estimates. Significance of enrichment was calculated using a Monte-Carlo simulation. Brain traits with enriched schizophrenia-set-based heritability at FDR q ⩽ 0.1 are highlighted with asterisk (***uncorrected P o0.001; **P o0.01; *Po0.05). FDR, false discovery rate; SNP, single-nucleotide polymorphism.
Genomic partitioning of SNP heritability shows a significantly enriched contribution of schizophrenia GWAS loci for several brain phenotypes Next, we examined how much of the genome-wide SNP heritability of these 35 brain anatomical traits is attributable to independently ascertained schizophrenia-associated genetic variants. Using genome-wide association results from the largest PGC schizophrenia study, we divided genotyped SNPs in our data set into two mutually exclusive sets: the top 10% of schizophrenia-associated SNPs and the remaining 90% of SNPs.
For each brain measure, we estimated genome-wide SNP heritability using a joint analysis of the two SNP sets. Finally, increased contribution of a schizophrenia-associated SNP set was quantified using Monte Carlo simulations as previously described (see Materials and Methods). 22, 27, 28 As summarized in Figure 1 and Table 2 , eight anatomical traits showed significantly enriched contribution of the schizophrenia-associated SNP set at FDR q = 0.1: (1) ICV (enrichment P = 2.61 × 10 ). Figure 2 shows the spatial distribution of the schizophrenia-associated SNP-based heritability estimates for the 35 brain phenotypes: cortical thickness (Figure 2a ) and surface area (Figure 2b ) across the entire cerebral cortex. We also confirmed that partitioned heritability estimates for ICV and superior frontal cortex thickness show consistently enriched contribution of schizophrenia-associated SNPs across varying SNP selection thresholds (10-50%; Supplementary Table 3 ).
The neurogenetic architecture of schizophrenia-associated brain phenotypes is partly shared with other psychiatric disorders There is compelling evidence that major psychiatric disorders share genetic vulnerability. 22, 43 We examined whether the eight brain phenotypes for which we found significant enrichment of schizophrenia-associated genetic variants, are also correlated with disease risk for other psychiatric disorders. This comparative analysis used publicly available GWAS results of five psychiatric disorders: (1) anorexia nervosa; (2) ADHD; (3) autism spectrum disorder; (4) bipolar disorder; and (5) major depressive disorder. We also included Crohn's disease as a non-psychiatric control data set. Partitioning and enrichment analyses were conducted for each disorder as previously described. After correcting for multiple testing (FDR q ⩽ 0.1), four brain phenotypes showed significant association with the examined psychiatric disorders. Figure 3 displays the comparative analysis results for the four brain Table 4) . ICV showed significantly enriched association with multiple disorders. As we observed with schizophrenia, ICV showed enrichment for ADHDassociated SNPs under all SNP selection thresholds (top 10-50%; enrichment P ⩽ 5.60 × 10 − 5 ). Genetic variants associated with another neurodevelopmental disorder autism spectrum disorder also showed a relationship to ICV (top 20%; P = 2.61 × 10 − 3 ). Right temporal pole surface area was enriched for SNPs associated with major depressive disorder (top 30-50%; P ⩽ 3.15 × 10 − 3 ) and anorexia nervosa (top 50%; P = 1.60 × 10 − 3 ), while left entorhinal cortex thickness showed enrichment for bipolar disorder risk SNPs (top 20, 30%; P ⩽ 3.52 × 10 −3 ). Finally, in contrast to the other three brain regions, left superior frontal gyrus thickness was associated only with schizophrenia genetic risk (top 10-40%; P ⩽ 6.99 × 10 − 3 ). As expected, 22 Crohn's disease-associated SNPs showed no significantly enriched contribution for any of the eight brain phenotypes we examined.
DISCUSSION
Using an unbiased investigation of 139 brain-wide cortical regions of interest in 1750 healthy young adults, we identified eight brain structural phenotypes for which individual differences are significantly modulated by schizophrenia-associated genetic variants en masse. We specifically focused on cortical measures as they are related to normal development, aging, cognitive functioning, as well as neurodevelopmental disorders. 44 In particular, cortical thickness reflects progressive changes of developmental processes that last from birth to adulthood and to aging, which are driven by axonal and dendrite remodeling, myelination and synaptic pruning that contribute to active modification of brain functional circuitry. [45] [46] [47] Cortical surface areas, on the other hand, have been suggested to develop independently from cortical thickness. 37 Variability in cortical surface areas and ICV is thought to reflect exceptionally dynamic early childhood developmental processes, including neural stem cell proliferation and migration. 44, 45 Genetic modulation of these biological processes may thus underlie a common genetic basis between brain anatomy and the etiology of neurodevelopmental disorders, such as schizophrenia.
Our study highlights several brain cortical regions as potential endophenotypes of schizophrenia. 9, 48 The identified regions include right temporal pole, left superior frontal, superior temporal, inferior parietal, lateral occipital and entorhinal cortices, and the cuneus. Although structural changes in a broad range of brain regions have been associated with schizophrenia in prior research, it has often been difficult to determine whether such correlations reflect shared etiologic factors or secondary effects of schizophrenia or its treatment on brain structure. Our findings support the hypothesis that these brain anatomical correlates share a common genetic basis with schizophrenia. Although these regions are anatomically distributed throughout the brain, most reside within the cortical association networks, which are disrupted in patients with psychotic disorders. 49 Our findings thus suggest that distributed cortical changes in these regions, which arise due to a shared genetic basis with schizophrenia, may lead to changes in large-scale anatomical and functional systems affected in schizophrenia.
Among the eight cortical phenotypes, we found ICV and superior frontal cortical thickness as most robustly related to schizophrenia genetic risk. In particular, cortical thickness in the left superior frontal gyrus (SFG) showed a very specific relationship with schizophrenia-associated genetic variants. This finding is consistent with a large body of literature implicating volumetric reductions in SFG in psychotic illness, including in (1) both unmedicated and medicated schizophrenia patients, 50 (2) child onset schizophrenia patients (who are believed to have increased genetic loading; see Ordóñez et al. 51 ) and (3) clinical high risk patients who ultimately convert to psychosis. 52 Reductions in cortical thickness in the superior frontal gyrus have also been demonstrated recently to be mediated by cognitive control deficits, 53 a core feature of schizophrenia that is associated with poor functional outcome. The SFG includes the dorsolateral prefrontal cortex and, as defined for the present analysis, is situated near the intersection of three large-scale cortical systems subserving higher cognitive functions, the fronto-parietal control network, the default network, and the dorsal attention network. 54 In particular, the left SFG is functionally connected to most of the default mode network and suggested to have a key role in information processing between the default mode network and a number of distributed fronto-parietal control networks. 55, 56 A series of studies have reported that patients with schizophrenia have exhibited distinct connectivity patterns compared with controls within 57, 58 and between 59,60 these two networks, each tied to key domains of cognition. The superior frontal gyrus is also among the cortical territories that have vastly expanded, as a proportion of overall cortical tissue, in humans versus other primates. 61 This expansion presumably provides adaptive advantages for human behavior and survival. Consistent with their recent origins, these territories also develop late during post-natal development, with cortical thinning-presumably reflecting synaptic pruning among other circuit refinement processesoccurring into late adolescence and early adulthood. 62 As this is the time window in which schizophrenia and related psychotic disorders typically present, it is intriguing to speculate that superior frontal gyrus thickness-one of the last structures to undergo developmental thinning-is a key neurogenetic correlate of schizophrenia that reflects either delayed or incomplete circuit refinements during the critical developmental period. This may lay the foundation for cognitive decline 63 and risk for psychotic experiences. 52, 64, 65 We also found that ICV, the phenotype most strongly associated with schizophrenia risk variants, is also associated with SNP sets contributing to other neurodevelopmental disorders, particularly ADHD, and a little lesser extent to autism spectrum disorder. Prior evidence suggests a genetic effect of disease liability on ICV in these three disorders. 2, 66, 67 In particular, reduced total brain gray matter volume was observed among unaffected relatives of individuals with schizophrenia [68] [69] [70] and ADHD. 66 ICV is a global measure of brain structure, and it thus may reflect the integration of multiple processes that have been implicated in diverse neurodevelopmental disorders, including altered neuronal migration and synaptic pruning.
In this work, we demonstrated the utility of partitioning-based SNP heritability analysis for investigating the shared genetic basis of two complex traits. Several other approaches aim to achieve the same goal. Polygenic scoring analysis 11 has been widely used in recent neuroimaging genetics work. 14, 15, 17, 33, 71 As opposed to standard single-SNP-based association analyses, polygenic scoring analysis uses genome-wide SNP data to relate aggregated disease risk scores to phenotypic differences. Estimated polygenic risk scores have shown impressive power for predicting case versus control status in independent disorder samples. 41 However, the polygenic scoring strategy has a limited utility if two complex traits do not preserve consistent directional effects at a genomewide level. This may have contributed to several recent studies that have discovered limited evidence for association between polygenic risk scores of schizophrenia and cortical 72 or subcortical neuroimaging phenotypes. 73 Bivariate analysis of the covariance between two traits, 74 as implemented in bivariate GCTA, is another popular approach. Using a multivariate linear mixedeffects model, this method estimates genetic correlation between two complex traits using SNP-derived genomic relationships. Bivariate GCTA however requires raw genotype data for both traits, which may not be readily available. Recently, another powerful SNP co-heritability analysis tool 75 has been developed that employs LD score regression. 29 This method estimates genetic correlation between two traits using only genome-wide summary statistics, and offers great utility for genetic studies of complex traits. Nevertheless, it requires a large sample Figure 3 . Enrichment analysis results for various disorder-associated SNP-set-based heritability. We examined seven disorders: (1) SCZ, schizophrenia; (2) ADHD, attention deficit hyperactivity disorder; (3) AUT, autism spectrum disorder; (4) AN, anorexia nervosa; (5) BIP, bipolar disorder; (6) MDD, major depressive disorder; and (7) CD, Crohn's disease. For each disorder, the results of publicly available genome-wide case/control association study were obtained from the Psychiatric Genomics Consortium and used to rank genotype SNPs based on the significance of disease association. The x-axis represents five SNP set selection thresholds: top 10, 20, 30, 40 and 50%. For each of the SNP selection thresholds, we divided genotype SNPs into two sets: (1) one set of top ranked disorder-associated SNPs within the selection threshold; and (2) the other set of the remaining genotype SNPs. GCTA was used to learn the genome-wide SNP heritability of a brain phenotype using a joint analysis of the two SNP set-based genetic components. The y-axis represents estimated SNP heritability contributable to the set of disorder-associated SNPs. Error bars represent the analytic s.e.'s of the estimates. Heritability estimates for seven disorders are displayed using solid navy-color bars, while the null expectations (that is, estimates calculated based on the proportion of SNPs with respect to the genome-wide SNP heritability of the corresponding brain phenotype) are marked by dashed gray-line bars. Brain phenotypes with enriched disorder-set-based heritability at FDR q ⩽ 0.1 are highlighted with asterisk (***uncorrected Po0.001; **P o0.01; *P o0.05). FDR, false discovery rate; SNP, single-nucleotide polymorphism.
size-typically tens of thousands of samples-to achieve reasonable statistical power. 30 Our study results should be interpreted in the context of several limitations. First, linear mixed-effects modeling used in this study only consider the contribution of additive genetic effects. A recent meta-analysis of 17 804 human traits reports a predominant contribution of additive genetic effects, 76 but non-additive genetic effects may have an important role in brain structure and function. 77 Similarly, our analysis does not include sex chromosome data, which may harbor relevant genetic contributions to disorder-related neuroanatomy. Second, SNP heritability analysis using mixed linear effects modeling is a useful tool to estimate what fraction of the phenotypic variance can be explained by a set of target variants en masse. However, it does not imply that the selected disease associated SNPs carry the same direction of effects for the studied brain phenotype, nor does it identify the most significantly associated variants. Third, we did not have statistical power to dissect the partitioned heritability attributed to by disease-associated SNPs into more finely defined categories (for example, specific chromosomes, functional categories or biological pathways). As neuroimaging sample sizes increase, we anticipate more fine-scaled partitioning of variance by annotation and genomic region will become feasible and thus facilitate the dissection of genetic architectures between disease and brain structural phenotypes. Finally, recent studies have noted nicotine usage could affect the brain structure and function, 78, 79 including the measures of cortical thickness and volume. The MGH/Harvard GSP samples include about 106 smokers (7.9%). We investigated whether there are statistically significant differences in major brain anatomical measures between a group of smokers and a demographically matched group of non-smokers in our sample (conditioning on age, sex, handedness, principal component analysis factors for ethnicity, and ICV for cortical volumetric measures). After regressing out covariates, the Wilcoxon rank sum test was used to compare the differences. In brief, we did not find statistically significant differences after performing multiple testing correction (at FDR q = 0.1; Supplementary Table 5 ). This null result is likely because, among a small proportion of smokers in our sample (N = 106; 7.9%), most were light daily smokers who use zero or one cigarette per day (N = 76; 6%). Considering a small proportion of daily smokers in our sample (o 8%), and nonsignificant differences in the brain morphometric measures between the groups of smokers and non-smokers, we decided not to include nicotine usage as a covariate in the present study. It is though possible that the long duration of smoking or the effects of the second-hand smoking exposure may lead to more extensive structural changes, which could not be tested in our sample due to lack of data.
In summary, our study demonstrates that certain brain anatomical phenotypes are influenced by genetic variants that also contribute to schizophrenia disease risk. Although the effect of common genetic variants is only modest individually, aggregate genomic effects account for a substantial proportion of the variance in brain measures. 25, 26, 42, 77 Further studies are warranted to elucidate the role of these neuroanatomical phenotypes in the pathogenesis of schizophrenia. Along with anatomical measures, brain connectivity and neural integrity are also key markers of neuropsychiatric disorders. Our future work will investigate the genetic overlap between brain functional connectivity and schizophrenia disease risk. For example, healthy individuals with heightened genetic risk and signs of structural changes may or may not exhibit concomitant changes in functional architecture. These changes might reflect compensatory processes in these ostensibly healthy individuals. In addition, studies of clinical samples may offer crucial information about how variation in cortical regions highlighted in our study are associated with genetic liability, symptom severity and treatment response.
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